Wet Macular Degeneration | sciencenewsnet.in

Breaking News

At the Roots of Business Ethics: A New Reading of the Merchant of Venice

Digital Science Teams Up with Huron to Strengthen Research Security and Compliance for Education and Research Clients

American Thyroid Association® Announces 2024-2025 Officers and Board of Directors

Diabetes Drug Appears to Fight Lung Cancer — But Only in Overweight or Obese Patients

Don’t Rock the Boat: The Social-symbolic Work to Confront Ethnic Discrimination in Branches of Professional Service Firms

Virtual replicas for real-world solutions: digital twins in action

Beyond lithium: the rise of sustainable battery alternatives

Novel Gene Therapy Trial for Sickle Cell Disease Launches

Behind the Model: Science Inspired by Legos

Quantifying disease impact and overcoming practical treatment barriers for primary progressive aphasia

26 Nov, 2024

Nanoparticles enhance gene therapies for eye disease

August 14, 2020 sarah JonasResearch Results

NIBIB-funded researchers have created nanoparticles for successful gene therapy of a mouse model of macular degeneration. The nanoparticle carriers have the potential to significantly expand the effectiveness of gene therapies for human eye diseases, including blindness.